GRISENDI, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.841
EU - Europa 8.028
AS - Asia 6.292
SA - Sud America 969
AF - Africa 148
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 5
Totale 29.336
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.543
SE - Svezia 2.338
IT - Italia 2.134
SG - Singapore 2.058
CN - Cina 1.497
GB - Regno Unito 1.372
VN - Vietnam 730
HK - Hong Kong 717
BR - Brasile 686
DE - Germania 567
RU - Federazione Russa 312
BD - Bangladesh 303
FI - Finlandia 267
FR - Francia 258
UA - Ucraina 176
TR - Turchia 153
ID - Indonesia 149
CA - Canada 142
KR - Corea 142
IN - India 125
MX - Messico 94
AR - Argentina 92
NL - Olanda 89
BG - Bulgaria 84
IE - Irlanda 61
IQ - Iraq 56
JP - Giappone 56
BE - Belgio 55
AU - Australia 51
PL - Polonia 50
ES - Italia 49
EC - Ecuador 44
ZA - Sudafrica 43
VE - Venezuela 40
PK - Pakistan 36
AE - Emirati Arabi Uniti 33
CL - Cile 30
CO - Colombia 27
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
MY - Malesia 24
AL - Albania 23
AT - Austria 22
LT - Lituania 22
CH - Svizzera 21
RO - Romania 20
MA - Marocco 19
JO - Giordania 18
NP - Nepal 17
SA - Arabia Saudita 16
DZ - Algeria 15
EG - Egitto 15
KE - Kenya 15
PE - Perù 15
PT - Portogallo 15
IR - Iran 14
PH - Filippine 14
IL - Israele 13
UY - Uruguay 13
BZ - Belize 12
OM - Oman 11
PY - Paraguay 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
TN - Tunisia 10
DO - Repubblica Dominicana 9
RS - Serbia 9
ET - Etiopia 8
MD - Moldavia 8
BO - Bolivia 7
BY - Bielorussia 7
LB - Libano 7
PA - Panama 7
SI - Slovenia 7
TH - Thailandia 7
TW - Taiwan 7
SN - Senegal 6
CR - Costa Rica 5
CY - Cipro 5
GR - Grecia 5
JM - Giamaica 5
LK - Sri Lanka 5
MT - Malta 5
SY - Repubblica araba siriana 5
BB - Barbados 4
DK - Danimarca 4
GT - Guatemala 4
HR - Croazia 4
NG - Nigeria 4
PR - Porto Rico 4
PS - Palestinian Territory 4
AM - Armenia 3
EE - Estonia 3
GE - Georgia 3
GY - Guiana 3
HU - Ungheria 3
KG - Kirghizistan 3
KH - Cambogia 3
LV - Lettonia 3
NI - Nicaragua 3
Totale 29.284
Salva come PNG Salva come JPEG
Città #
Stockholm 1.795
Ashburn 1.530
Singapore 1.394
Fairfield 1.345
Santa Clara 1.235
Southend 798
Chandler 745
Woodbridge 697
Hong Kong 696
Houston 612
San Jose 601
Seattle 479
Cambridge 437
Ann Arbor 422
Wilmington 422
Nyköping 346
Council Bluffs 338
Hefei 328
Beijing 310
Modena 306
New York 284
London 273
Los Angeles 273
Dearborn 263
Jacksonville 253
Ho Chi Minh City 223
Bologna 217
Helsinki 200
Hanoi 189
Milan 175
The Dalles 161
Chicago 157
Munich 136
Seoul 133
San Diego 130
Jakarta 121
Frankfurt am Main 107
Shanghai 98
Lauterbourg 84
Princeton 84
Moscow 79
Sofia 78
Izmir 77
Dallas 76
Buffalo 73
Parma 68
São Paulo 67
Fremont 63
Orem 62
Rome 61
Eugene 58
Dublin 56
Boardman 52
Salt Lake City 50
Brussels 48
Phoenix 46
Bremen 42
Montreal 40
Mexico City 39
Tokyo 39
Guangzhou 38
Warsaw 37
Columbus 36
Reggio Emilia 35
Atlanta 34
Da Nang 34
Nuremberg 33
Chennai 32
San Giuliano Milanese 31
Falls Church 30
Denver 29
Hillsboro 29
Toronto 28
Haiphong 26
Johannesburg 26
Redwood City 26
Brooklyn 25
Tampa 25
Amsterdam 24
Elk Grove Village 24
Grafing 23
Poplar 23
Rio de Janeiro 23
Florence 22
Manchester 22
Baghdad 21
Des Moines 21
Lancaster 21
Norwalk 21
Ravenna 21
Redondo Beach 21
San Francisco 21
Sydney 21
Mumbai 20
Portsmouth 20
Tashkent 20
Boston 18
Turku 18
Naples 17
Paris 17
Totale 20.584
Salva come PNG Salva come JPEG
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.216
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 503
CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish 501
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 477
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 456
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 431
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 427
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 426
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 422
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 409
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 393
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 393
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 391
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 387
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 381
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 375
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 367
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 365
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 361
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 356
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 355
Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro 346
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 344
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 338
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 338
Tumor Stroma Manipulation By MSC 334
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 333
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 332
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 330
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 324
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 324
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 319
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 317
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 316
Detection of microparticles from human red blood cells by multiparametric flow cytometry 315
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 313
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 306
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 305
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 301
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 294
GD2 CAR T cells against human glioblastoma 294
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 287
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 285
An adoptive immuno-gene therapy approach targeting neuroblastoma. 284
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 280
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 279
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 279
Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors 278
IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation 270
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 270
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 269
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review 267
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 265
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 260
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 254
Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis 251
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 250
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 244
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models 244
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 243
Scleral ossicles as natural biomaterials on which vascular-like network is promoted from Mouse Aortic Endothelial cells (MAECs): preliminary results 242
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 242
Challenging the efficacy of checkpoint inhibitors: a new 3D model for a precision medicine approach. 239
Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9) 238
Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. 238
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma 236
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 234
Cancer stem cells and their microenvironment. 234
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 232
New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem Cells. 229
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 225
Staminali per la cura del tumore del pancreas: tra evidenze scienti che e possibile trasferimento clinico 225
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells 225
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 224
Stem cells and lung cancer : between advanced diagnostics and new therapeutics. 220
Sarcomas as a mise en abyme of Mesenchymal Stem Cells; exploiting interrelationships for cell mediated anticancer therapy 213
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 213
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 206
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study 201
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 198
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine 190
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance 189
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 182
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 181
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 178
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 173
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 170
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence 169
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 164
Refining GMP-manufactured density gradient media for optimised mesenchymal stromal/stem cell isolation and expansion. 162
The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study 154
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 154
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro 154
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 153
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy 135
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 133
Persistency of Mesenchymal Stromal/Stem Cells in Lungs 133
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 128
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations 117
Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer 106
Totale 29.513
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.303 106 321 233 90 78 123 177 145 216 163 414 237
2022/20232.267 259 278 189 241 231 265 63 216 260 26 124 115
2023/20241.494 101 88 113 155 280 181 102 138 36 51 71 178
2024/20255.067 144 90 184 372 850 859 501 263 527 254 402 621
2025/202611.389 633 332 669 1.134 1.592 559 1.170 470 2.678 993 719 440
2026/2027232 232 0 0 0 0 0 0 0 0 0 0 0
Totale 29.626